Stella Diagnostics (Stella Diagnostics) Operating Cash Flow per Share : $ (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Operating Cash Flow per Share?

Stella Diagnostics's operating cash flow per share for the three months ended in Sep. 2023 was $0.00. Stella Diagnostics does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Stella Diagnostics's Operating Cash Flow per Share or its related term are showing as below:

SLDX's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Stella Diagnostics Operating Cash Flow per Share Historical Data

The historical data trend for Stella Diagnostics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Operating Cash Flow per Share Chart

Stella Diagnostics Annual Data

Trend

Operating Cash Flow per Share

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Operating Cash Flow per Share	-	-

Competitive Comparison of Stella Diagnostics's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Stella Diagnostics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Price-to-Operating-Cash-Flow falls into.

Stella Diagnostics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Stella Diagnostics's Operating Cash Flow per Share for the fiscal year that ended in . 20 is calculated as

Operating Cash Flow per Share (A: . 20 )	=	Cash Flow from Operations (A: . 20 )	/	Shares Outstanding (Diluted Average) (A: . 20 )
	=		/	0
	=

Stella Diagnostics's Operating Cash Flow per Share for the quarter that ended in . 20 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	0	/	401.600
	=	0.00

Stella Diagnostics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.